arrow
M

Marc Peeters

University of Antwerp
H指数:99
被引数:4.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)

MEK1/2抑制剂比尼美替尼与MET抑制剂克唑替尼在RAS突变型晚期结直肠癌 (汞) 患者中的Ia/b期研究

2025-04-100
OAAI
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome (vol 18, 9, 2025)

WT1-mRNA树突状细胞疫苗治疗胶质母细胞瘤多形性、恶性胸膜间皮瘤、转移性乳腺癌及其他实体瘤:Ⅰ型T淋巴细胞反应与临床结局相关(卷18,第9期,2025年)

2025-03-190
OA
Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients
2025-03-060
OAAI
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors
2024-11-190
OAAI
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness

来自表皮生长因子受体抑制剂与贝伐单抗在RAS野生型转移性结直肠癌成年患者中的头对头一线试验的疗效和安全性数据的荟萃分析

2024-05-016
PRE